{"id":"W1963505416","doi":"10.1002/hep.26275","title":"JUMP-C: A Randomized Trial of Mericitabine Plus Pegylated Interferon Alpha-2a/Ribavirin for 24 Weeks in Treatment-NaÏVe HCV Genotype 1/4 Patients","year":2013,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; University of British Columbia","funders":"","keywords":"Ribavirin; Medicine; Internal medicine; Gastroenterology; Placebo; Hepatitis C virus; Pegylated interferon; Randomized controlled trial; Hepatitis C; NS5B; Alpha interferon; Confidence interval; Hepacivirus; Interferon; Immunology; Virus; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001183017,0.001697945,0.002534267,0.0003418687,0.0005096455,0.000955552,0.0009256136,0.001955556,0.008389509],"category_scores_gemma":[0.001185995,0.0006380156,0.001417142,0.0002955034,0.001299428,0.000914033,0.0004933004,0.002721302,0.0008791743],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006334326,"about_ca_system_score_gemma":0.001079568,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001206482,"about_ca_topic_score_gemma":0.002739271,"domain_scores_codex":[0.999529,0.0002550685,0.00003191565,0.00007450684,0.0000293515,0.00008021978],"domain_scores_gemma":[0.9993106,0.0001557845,0.0001513836,0.00003747729,0.00004055087,0.0003042502],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9897209,0.002148361,0.0002701444,0.0004041953,0.0003041831,0.00001982899,0.00001864183,0.0001138356,0.001180023,0.00004009338,0.0002650649,0.005514775],"study_design_scores_gemma":[0.9694285,0.02914774,0.0006896881,0.00001797997,0.0002013295,0.00001341391,0.000009795584,0.0001256559,0.0001361601,0.00003828687,0.0001853009,0.000006288659],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9885579,0.004095973,0.00030075,0.0007567033,0.0007646756,0.003198312,0.0006878088,0.0001269465,0.001510735],"genre_scores_gemma":[0.987346,0.002135376,0.0009759746,0.001219369,0.0006503551,0.003521753,0.0008292093,0.00001674487,0.003305216],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008389509,"threshold_uncertainty_score":0.02806568,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03793468779822394,"score_gpt":0.3338384834654721,"score_spread":0.2959037956672482,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}